Stanozolol by Galaxy Pharmaceuticals is a C17-alpha-alkylated DHT-derived steroidal compound distinguished by a fused pyrazole ring within the steroid nucleus, with a traditionally assigned anabolic/androgenic ratio of 320/20. Presented at 10 mg per tablet in a pack of 100 tablets.
Stanozolol by Galaxy Pharmaceuticals contains Stanozolol, a synthetic steroidal compound derived from the dihydrotestosterone structural family.
Stanozolol is structurally distinguished by the presence of a fused pyrazole ring within the steroid nucleus and a 17-alpha methyl group, classifying it as a C17-alpha-alkylated heterocyclic steroidal compound. These structural modifications differentiate Stanozolol from conventional testosterone-derived and esterified steroid compounds.
Stanozolol is traditionally associated with an anabolic/androgenic reference ratio of approximately 320/20, using testosterone at 100/100 as the standard reference point.
Galaxy Pharmaceuticals Stanozolol is presented at a strength of 10 mg per tablet and supplied in packs of 100 tablets, with clearly defined compound identity and dosage strength.
This description is provided solely for general product identification and technical information. Galaxy Pharmaceuticals products are intended for professional and research use only.
